Back to results
US 12,605,414 B2Granted
Discovery of novel Akkermansia muciniphila AK32 and application thereof for improving intestinal function
AssigneesThe Asan Foundation, University of Ulsan Foundation for Industry Cooperation
InventorsMi-Na Kweon, Seungil Kim
Life of this patent
Estimating the term…
Abstract
An Akkermansia muciniphila AK32 (Accession No. KCTC 14172BP) strain. The Akkermansia muciniphila AK32 strain prevents or improves intestinal damage. A method for preventing, improving or treating intestinal damage, including administering to a subject an effective amount of the Akkermansia muciniphila AK32 strain or a culture thereof as an active ingredient.
Claims3
A method for improving intestinal function, the method comprising:
- administering to a subject an effective amount of Akkermansia muciniphila strain AK32 or a culture thereof as an active ingredient;
- wherein the Akkermansia muciniphila AK32 strain is the strain deposited at the Korean Collection for Type Cultures, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 181, Ipsin-gil, Jeongeup-si, Jeollabuk-do 56212, Republic of Korea, on Apr. 20, 2020, under Accession No. KCTC 14172BP.
Dependencies are inferred from the claim text.